Pharmacogenomics:

Personalizing Medications for Improved Patient Care and Cost Reduction

Sign Up

On November 19, 2020, a Virtual Congressional Briefing shed light on what pharmacogenomics (PGx) is and why testing and alerting clinicians on each patient’s unique genetic response to prescription medications can improve patient care, prevent patient harm and even death, reduce days in hospitals and emergency room visits, and lower health care expenditures. We heard from world renown physicians and researchers experienced in caring for Medicare and Medicaid beneficiaries, Veterans and families on how broad adoption of PGx can stop the current rate of someone dying every 2 minutes from an adverse drug event (ADE) and save up to half a trillion dollars per year.

Resources

Watch the Briefing

View the Slide Deck